Terug
35
Ook genoteerd als
TCYMF
OTC
Dagbereik
€ 31,18
€ 32,77
52-Weeksbereik
€ 26,20
€ 37,30
Volume
202
50D / 200D Gem.
€ 32,34
/
€ 30,11
Vorige Slotkoers
€ 32,75
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 2,5 | 10,4 |
| P/B | 0,7 | 1,2 |
| ROE % | 26,6 | 12,6 |
| Net Margin % | 4,6 | 5,3 |
| Rev Growth 5Y % | 4,5 | 5,5 |
| D/E | 1,0 | 0,6 |
Belangrijkste Punten
Revenue grew 4,50% annually over 5 years — modest growth
Earnings grew 19,79% over the past year
ROE of 26,56% indicates high profitability
Generating 4,66B in free cash flow
P/E of 2,46 — trading at a low valuation
PEG of 0,71 suggests growth is underpriced
Groei
Revenue Growth (5Y)
4,50%
Revenue (1Y)0,29%
Earnings (1Y)19,79%
FCF Growth (3Y)94,05%
Kwaliteit
Return on Equity
26,56%
ROIC15,90%
Net Margin4,63%
Op. Margin7,29%
Veiligheid
Debt / Equity
0,95
Current Ratio0,55
Interest Coverage13,90
Waardering
P/E Ratio
2,46
P/B Ratio0,65
EV/EBITDA2,58
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,29% | Revenue Growth (3Y) | 1,22% |
| Earnings Growth (1Y) | 19,79% | Earnings Growth (3Y) | 19,11% |
| Revenue Growth (5Y) | 4,50% | Earnings Growth (5Y) | -2,08% |
| Profitability | |||
| Revenue (TTM) | 80,65B | Net Income (TTM) | 3,73B |
| ROE | 26,56% | ROA | 7,03% |
| Gross Margin | 33,10% | Operating Margin | 7,29% |
| Net Margin | 4,63% | Free Cash Flow (TTM) | 4,66B |
| ROIC | 15,90% | FCF Growth (3Y) | 94,05% |
| Safety | |||
| Debt / Equity | 0,95 | Current Ratio | 0,55 |
| Interest Coverage | 13,90 | Dividend Yield | 0,06% |
| Valuation | |||
| P/E Ratio | 2,46 | P/B Ratio | 0,65 |
| P/S Ratio | 0,11 | PEG Ratio | 0,71 |
| EV/EBITDA | 2,58 | Dividend Yield | 0,06% |
| Market Cap | 9,20B | Enterprise Value | 15,20B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 80,65B | 80,42B | 78,72B | 74,08B | 67,62B |
| Net Income | 3,73B | 3,12B | 2,63B | 3,80B | 4,06B |
| EPS (Diluted) | 13,20 | 11,00 | 9,40 | 13,60 | 14,40 |
| Gross Profit | 26,70B | 24,47B | 22,90B | 22,51B | 22,43B |
| Operating Income | 5,88B | 3,91B | 3,33B | 4,33B | 5,99B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 53,15B | 53,15B | 58,45B | 60,31B | 61,53B |
| Total Liabilities | 35,53B | 35,93B | 41,63B | 37,90B | 36,79B |
| Shareholders' Equity | 14,23B | 13,89B | 13,37B | 18,66B | 21,11B |
| Total Debt | 13,52B | 14,06B | 17,92B | 14,02B | 14,01B |
| Cash & Equivalents | 7,52B | 6,75B | 12,32B | 15,84B | 21,39B |
| Current Assets | 17,99B | 20,47B | 24,03B | 25,67B | 28,70B |
| Current Liabilities | 32,42B | 29,19B | 31,70B | 29,83B | 27,07B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#273 of 658
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026